斑秃长期随访研究:104例患者分析
该回顾性研究评估了104例斑秃患者的长期病程,按童年、成年和晚发起病分组。结果显示,晚发起病者严重病变比例更低、初始发作持续时间更短、无病间期更长且复发率更低;复发多发生在病程早期,现有治疗方式似不影响长期结局。
要点
- 晚发起病者严重病变比例更低,初始发作持续时间更短,无病间期更长。
- 复发率在童年、成年和晚发起病组分别为52%、44%和30%,多数复发发生在最初4年内。
- 现有治疗方式似不影响斑秃的长期结局。
核心结论
- 严重病变的患病率、初始发作持续时间和复发率随起病年龄增长而降低。
- 结局和无病间期随起病年龄增长而改善。
- 复发频率随时间下降,且多数复发出现较早。
- 当前治疗方式似不影响长期结局。
研究设计与样本
- 回顾性评估2008至2011年新诊断且随访至少7年的斑秃患者。
- 共分析104例:童年起病31例,成年起病63例,晚发起病10例。
主要发现
- 首次发作时,88.5%患者为轻度,3.8%为中度,7.7%为重度。
- 童年、成年和晚发起病组完全或显著再生分别见于74%、94%和100%的患者。
- 无再生分别见于13%、3%和0%的童年、成年和晚发起病患者。
- 初始发作持续时间和无病间期与年龄呈负相关。
- 复发频率总体较高(童年52%、成年44%、晚发30%),但随时间显著下降,79%的复发发生在最初4年内。
关键数值与推荐
- 全身性类固醇是初始发作最有效的治疗。
临床怎么用
- 对斑秃患者应关注起病年龄对长期病程的预测价值。
- 复发多发生在最初4年内,此期间需加强随访。
- 现有治疗方式对长期结局影响有限,需个体化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alopecia areata (AA) is a common autoimmune disease that considerably affects the quality of life. Although several studies have investigated the epidemiology, clinical characteristics and treatment of AA, limited recent data are available regarding its long-term course. OBJECTIVES: To evaluate the long-term course of AA in different age groups. METHODS: A retrospective evaluation of patients who were newly diagnosed with AA from 2008 to 2011 and had at least 7 years of follow-up. Data regarding the initial episode, treatment given, disease-free interval and relapses were analysed. RESULTS: A total of 104 cases were analysed: 31 childhood-onset, 63 adult-onset and 10 late-onset. At first episode, 88.5% of patients had mild, 3.8% moderate and 7.7% severe AA. Full or significant re-growth was observed in 74%, 94% and 100% of childhood-onset, adult-onset and late-onset AA patients, respectively. There was no re-growth in 13%, 3% and 0% of childhood-onset, adult-onset and late-onset patients, respectively. The duration of the initial episode and the disease-free interval negatively correlated with age. Systemic steroids were the most effective treatment for the primary episode. The frequency of relapses was high overall (52%, 44% and 30% in childhood-onset, adult-onset and late-onset, respectively), but significantly declined over time with a majority (79%) occurring within the first 4 years. The disease-free interval and relapse rate were not correlated with gender, disease severity at onset or treatment given. CONCLUSIONS: The prevalence of severe disease, duration of an initial episode and the rate of relapses decreased with an older age at onset. In addition, the outcome and the disease-free interval improved with age at onset. The frequency of relapses declined over time and most appear early on. The current treatment modalities do not seem to influence the long-term outcome.
引用
- Lyakhovitsky A, Aronovich A, Gilboa S, et al. Alopecia areata: a long-term follow-up study of 104 patients. J Eur Acad Dermatol Venereol. 2019. PMID: 30887594. doi:10.1111/jdv.15582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。